Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist

World Journal of Hepatology

Volumn 7, Issue 5, 2015, Pages 799-805

  Modha, Kunjam ^a   Navaneethan, Udayakumar ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FLORIDA HOSPITAL   (United States)

Author keywords

Bile; Dominant strictures; Endoscopy; Primary sclerosing cholangitis; Therapeutic endoscopy

Indexed keywords

EID: 84928998088     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i5.799     Document Type: Article

References (60)

1. Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 1598-1619 [PMID: 20198712 DOI: 10.1002/ibd.21219]
2. Gohlke F, Lohse AW, Dienes HP, Löhr H, Märker-Hermann E, Gerken G, Meyer zum Büschenfelde KH. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24: 699-705 [PMID: 8835745 DOI: 10.1016/S0168-8278(96)80266-2]
3. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369 [PMID: 14598252 DOI: 10.1016/j. gastro.2003.07.011]
4. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149: 39-44 [PMID: 6412283 DOI: 10.1148/ radiology.149.1.6412283]
5. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-933 [PMID: 7877651 DOI: 10.1056/ NEJM199504063321406]
6. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 3310-3313 [PMID: 10566735 DOI: 10.1111/j.1572-0241.1999.01543.x]
7. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-678 [PMID: 20101749 DOI: 10.1002/hep.23294]
8. Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 2003; 98: 1155-1158 [PMID: 12809842 DOI: 10.1111/j. 1572-0241.2003.074 01.x]
9. Angulo P, Pearce DH, Johnson CD, Henry JJ, LaRusso NF, Petersen BT, Lindor KD. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol 2000; 33: 520-527 [PMID: 11059855 DOI: 10.1034/j.1600-0641.2000.033004520.x]
10. Dave M, Elmunzer BJ, Dwamena BA, Higgins PD. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010; 256: 387-396 [PMID: 20656832 DOI: 10.1148/radiol.10091953]
11. Navaneethan U, Jegadeesan R, Nayak S, Lourdusamy V, Sanaka MR, Vargo JJ, Parsi MA. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc 2015; 81: 410-419 [PMID: 25085336]
12. Björnsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 502-508 [PMID: 15056092 DOI: 10.1111/j.1572-0241.2004.04106.x]
13. Enns R, Eloubeidi MA, Mergener K, Jowell PS, Branch MS, Baillie J. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. Can J Gastroenterol 2003; 17: 243-248 [PMID: 12704468]
14. Aljiffry M, Renfrew PD, Walsh MJ, Laryea M, Molinari M. Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB (Oxford) 2011; 13: 79-90 [PMID: 21241424 DOI: 10.1111/ j.1477-2574.2010.00268.x]
15. Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns MP. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 1996; 28: 546-551 [PMID: 8911801 DOI: 10.1055/s-2007-1005552]
16. Ahrendt SA, Pitt HA, Kalloo AN, Venbrux AC, Klein AS, Herlong HF, Coleman J, Lillemoe KD, Cameron JL. Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg 1998; 227: 412-423 [PMID: 9527065 DOI: 10.1097/00000658-199803000-00 014]
17. Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, Mulder CJ, Reitsma JB, Heisterkamp SH, Tytgat GN. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51: 562-566 [PMID: 12235081 DOI: 10.1136/gut.51.4.562]
18. Olsson RG, Asztély MS. Prognostic value of cholangiography in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 1995; 7: 251-254 [PMID: 7743307]
19. Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF. Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. AJR Am J Roentgenol 1991; 157: 959-964 [PMID: 1927817 DOI: 10.2214/ajr.157.5.1927817]
20. Kaya M, Petersen BT, Angulo P, Baron TH, Andrews JC, Gostout CJ, Lindor KD. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001; 96: 1059-1066 [PMID: 11316147 DOI: 10.1111/j. 1572-0241. 2001.03690.x]
21. Michaels A, Levy C. Endoscopic and surgical management of primary sclerosing cholangitis. Medscape J Med 2008; 10: 242 [PMID: 19099036]
22. Abu-Wasel B, Keough V, Renfrew PD, Molinari M. Biliary stent therapy for dominant strictures in patients affected by primary sclerosing cholangitis. Pathobiology 2013; 80: 182-193 [PMID: 23652282 DOI: 10.1159/000347057]
23. Gotthardt DN, Rudolph G, Klöters-Plachky P, Kulaksiz H, Stiehl A. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 2010; 71: 527-534 [PMID: 20189511 DOI: 10.1016/j. gie.2009.10.041]
24. van Milligen de Wit AW, van Bracht J, Rauws EA, Jones EA, Tytgat GN, Huibregtse K. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1996; 44: 293-299 [PMID: 8885349 DOI: 10.1016/S0016-5107(96)70167-0]
25. van Milligen de Wit AW, Rauws EA, van Bracht J, Mulder CJ, Jones EA, Tytgat GN, Huibregtse K. Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1997; 46: 344-347 [PMID: 9351039 DOI: 10.1016/S0016-5107(97) 70123-8]
26. Ponsioen CY, Lam K, van Milligen de Wit AW, Huibregtse K, Tytgat GN. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 2403-2407 [PMID: 10483999 DOI: 10.1111/j. 1572-0241.1999.013 64.x]
27. Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001; 53: 308-312 [PMID: 11231388 DOI: 10.1016/S0016-5107(01)70403-8]
28. Gluck M, Cantone NR, Brandabur JJ, Patterson DJ, Bredfeldt JE, Kozarek RA. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol 2008; 42: 1032-1039 [PMID: 18580600 DOI: 10.1097/MCG.0b013e3181646713]
29. Stiehl A, Rudolph G, Klöters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002; 36: 151-156 [PMID: 11830325 DOI: 10.1016/S0168-8278(01)00251-3]
30. Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 2002; 35: 1494-1500 [PMID: 12029635 DOI: 10.1053/jhep. 2002.33202]
31. Björnsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002; 51: 731-735 [PMID: 12377815 DOI: 10.1136/gut.51.5.731]
32. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000; 31: 7-11 [PMID: 10613720 DOI: 10.1002/hep.510310103]
33. Rudolph G, Gotthardt D, Klöters-Plachky P, Kulaksiz H, Rost D, Stiehl A. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 2009; 51: 149-155 [PMID: 19410324 DOI: 10.1016/j. jhep.2009.01.023]
34. Rudolph G, Gotthardt D, Kloeters-Plachky P, Rost D, Kulaksiz H, Stiehl A. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival. J Hepatol 2010; 53: 313-317 [PMID: 20472317 DOI: 10.1016/j. jhep.2010.02.030]
35. Chapman MH, Webster GJ, Bannoo S, Johnson GJ, Wittmann J, Pereira SP. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol 2012; 24: 1051-1058 [PMID: 22653260 DOI: 10.1097/MEG.0b013e3283554bbf]
36. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-25 [PMID: 1845927 DOI: 10.1097/00000 658-199101000-00004]
37. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009; 50: 158-164 [PMID: 19012991 DOI: 10.1016/ j.jhep.2008.08.013]
38. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005; 50: 1734-1740 [PMID: 16133981 DOI: 10.1007/s10620-005-2927-8]
39. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-1117 [PMID: 18785620 DOI: 10.1002/ hep.22441]
40. Trikudanathan G, Navaneethan U, Njei B, Vargo JJ, Parsi MA. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and metaanalysis. Gastrointest Endosc 2014; 79: 783-789 [PMID: 24140129 DOI: 10.1016/j.gie.2013.09.015]
41. Zhang F, Zhao D, Wang S, Hong L, Li Q. Aneuploidy directly contribute to carcinogenesis by disrupting the asymmetric division of adult stem cells. Med Hypotheses 2007; 68: 237-238 [PMID: 16890378 DOI: 10.1016/j.mehy.2006.06.007]
42. Bergquist A, Tribukait B, Glaumann H, Broomé U. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol 2000; 33: 873-877 [PMID: 11131447 DOI: 10.1016/S0168-8278(00)80117-8]
43. Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, Barr Fritcher EG, Levy MJ, Gores GJ. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006; 131: 1064-1072 [PMID: 17030177 DOI: 10.1053/j.gastro.2006.08.021]
44. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99: 1675-1681 [PMID: 15330900 DOI: 10.1111/j. 1572-0241. 2004.30281.x]
45. Barr Fritcher EG, Voss JS, Jenkins SM, Lingineni RK, Clayton AC, Roberts LR, Halling KC, Talwalkar JA, Gores GJ, Kipp BR. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy. Cancer Cytopathol 2013; 121: 708-717 [PMID: 23839915 DOI: 10.1002/cncy.21331]
46. Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, Lindor KD. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 2010; 51: 174-180 [PMID: 19877179 DOI: 10.1002/hep.23277]
47. Navaneethan U, Njei B, Venkatesh PG, Vargo JJ, Parsi MA. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and metaanalysis. Gastrointest Endosc 2014; 79: 943-950. e3 [PMID: 24360654 DOI: 10.1016/j.gie.2013.11.001]
48. Barr Fritcher EG, Kipp BR, Voss JS, Clayton AC, Lindor KD, Halling KC, Gores GJ. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol 2011; 106: 2023-2028 [PMID: 21844920 DOI: 10.1038/ajg.2011.272]
49. Meining A, Saur D, Bajbouj M, Becker V, Peltier E, Höfler H, von Weyhern CH, Schmid RM, Prinz C. In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. Clin Gastroenterol Hepatol 2007; 5: 1261-1267 [PMID: 17689297 DOI: 10.1016/ j.cgh.2007.05.019]
50. Meining A, Chen YK, Pleskow D, Stevens P, Shah RJ, Chuttani R, Michalek J, Slivka A. Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience. Gastrointest Endosc 2011; 74: 961-968 [PMID: 21802675 DOI: 10.1016/j. gie.2011.05.009]
51. Meining A, Shah RJ, Slivka A, Pleskow D, Chuttani R, Stevens PD, Becker V, Chen YK. Classification of probe-based confocal laser endomicroscopy findings in pancreaticobiliary strictures. Endoscopy 2012; 44: 251-257 [PMID: 22261749 DOI: 10.1055/ s-0031-1291545]
52. Giovannini M, Bories E, Monges G, Pesenti C, Caillol F, Delpero JR. Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis. Surg Endosc 2011; 25: 2247-2253 [PMID: 21424206 DOI: 10.1007/s00464-010-1542-8]
53. Caillol F, Filoche B, Gaidhane M, Kahaleh M. Refined probebased confocal laser endomicroscopy classification for biliary strictures: the Paris Classification. Dig Dis Sci 2013; 58: 1784-1789 [PMID: 23314855 DOI: 10.1007/s10620-012-2533-5]
54. Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci 2013; 58: 2068-2074 [PMID: 23475187 DOI: 10.1007/s10620-013-2608-y]
55. Tischendorf JJ, Meier PN, Schneider A, Manns MP, Krüger M. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2007; 42: 1011-1017 [PMID: 17613933 DOI: 10.1080/00365520701206761]
56. Tischendorf JJ, Krüger M, Trautwein C, Duckstein N, Schneider A, Manns MP, Meier PN. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 2006; 38: 665-669 [PMID: 16673310 DOI: 10.1055/s-2006-925257]
57. Liu R, Cox Rn K, Siddiqui A, Feurer M, Baron T, Adler DG. Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma. Minerva Gastroenterol Dietol 2014; 60: 127-133 [PMID: 24780947]
58. Azeem N, Gostout CJ, Knipschield M, Baron TH. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc 2014; 79: 773-779. e2 [PMID: 24206748]
59. Navaneethan U, Gutierrez NG, Venkatesh PG, Jegadeesan R, Zhang R, Jang S, Sanaka MR, Vargo JJ, Parsi MA, Feldstein AE, Stevens T. Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study. Am J Gastroenterol 2014; 109: 895-902 [PMID: 24710507 DOI: 10.1038/ajg.2014.60]
60. Navaneethan U, Parsi MA, Lourdusamy V, Bhatt A, Gutierrez NG, Grove D, Sanaka MR, Hammel JP, Stevens T, Vargo JJ, Dweik RA. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study. Gastrointest Endosc 2015; 81: 943-949. e1 [PMID: 25500329 DOI: 10.1016/j.gie.2014.09.041]